Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
fatty liver disease is characterized by low antioxidants, disturbed lipid metabolism, cardioautonomic functions, and elevated blood measures (glucose, inflammatory markers, liver enzymes)
In fatty liver patients,applied cupping (with scarification) will be compared, regarding its effect on antioxidant, lipid metabolism, cardioautonomic functions, and blood measures (glucose, inflammatory markers, liver enzymes), to application of laser on acupoints
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| laser on acupuncture points | Active Comparator | In fatty liver diseased patients which their number will be 30 patients, a 3-session/week application of 2-minute laser (for 3 months) on acupoint number 25,40,36 of stomach meridian, acupoints number 3 and 14 of liver meridian, acupoint number 6 of spleen meridian,acupoint number 9.12,4 of conception vessel meridian, acupoint number 14 of governor vessel meridian, acupoint number 4, 11 of large intestine meridian, acupoint number 34 of gall bladder meridian |
|
| cupping (with scarification) | Active Comparator | in this fatty liver diseased patients which their number will be 30, cupping (with scarification) or wet cupping will be applied at the first day and the day number 14 in the month for three successive months. cupping (with scarification) or wet cupping will be applied on urinary bladder acupoint 17 (on the both sides) and governosal vessels acupoints 12,13,and 14. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| laser acupuncture | Device | In fatty liver diseased patients which their number will be 30 patients, a 3-session/week application of 2-minute laser (for 3 months) on acupoint number 25,40,36 of stomach meridian, acupoints number 3 and 14 of liver meridian, acupoint number 6 of spleen meridian,acupoint number 9.12,4 of conception vessel meridian, acupoint number 14 of governor vessel meridian, acupoint number 4, 11 of large intestine meridian, acupoint number 34 of gall bladder meridian |
| Measure | Description | Time Frame |
|---|---|---|
| high density lipoprotein | it is a component of lipid profile | 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| cholesterol | it is a component of lipid profile | 12 weeks |
| low density lipoprotein | it is a component of lipid profile | 12 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
thoracic diseases heart diseases kidney diseases
based on self-representation of gender identity.
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ali Ismail, lecturer | Contact | 02 01005154209 | ali.mohamed@pt.cu.edu.eg | |
| ahmed Elfahl, Lecturer | Contact | ahmed.elfahl@buc.edu.eg |
| Name | Affiliation | Role |
|---|---|---|
| Ali Ismail, lecturer | Cairo University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cairo Unoversity | Recruiting | Giza | Egypt |
Not provided
| ID | Term |
|---|---|
| D005234 | Fatty Liver |
| ID | Term |
|---|---|
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| wet cupping | Other | in this fatty liver diseased patients which their number will be 30, cupping (with scarification) or wet cupping will be applied at the first day and the day number 14 in the month for three successive months. cupping (with scarification) or wet cupping will be applied on urinary bladder acupoint 17 (on the both sides) and governosal vessels acupoints 12,13,and 14. |
|
| triglycerides | it is a component of lipid profile | 12 weeks |
| blood glucose | fasting level of blood glucose will be measured | 12 weeks |
| C reactive protein | high sensitivity levels C reactive protein will be measured | 12 weeks |
| Malondialdehyde | it ts oxidative stress marker | 12 weeks |
| aspartate transaminase | it is a hepatic enzyme that reports the functions of liver | 12 weeks |
| alanine transaminase | it is a hepatic enzyme that reports the functions of liver | 12 weeks |
| systolic blood pressure | it will be measured by sphygmomanometer | 12 weeks |
| diastolic blood pressure | it will be measured by sphygmomanometer | 12 weeks |
| pulse rate | it will be measured manually | 12 weeks |